Quanterix Corporation (QTRX)
Healthcare
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 2
Do Nothing: fundamentalScore 2 and qualitativeScore 2 are below the required floor of 3, and the stock also fails the $5M 20-day dollar-volume floor plus the 5% overnight-gap gate.
Company overview
Quanterix Corporation, headquartered in Billerica, Massachusetts, develops and markets advanced digital immunoassay platforms for precision health applications in scientific research and diagnostics. The company offers instruments like the HD-X, SR-X, and SP-X, along with consumables and contract research services, targeting critical health areas such as neurology, oncology, and cardiology.
Fundamental
weakQuanterix shows revenue growth but remains deeply unprofitable with significant cash burn and execution risks.
Quanterix has decent liquidity and trades at a low EV/Sales multiple, but it remains heavily loss-making with large negative free cash flow and distressed financial-health signals. Recent SEC filings show revenue growth boosted by acquisitions, alongside goodwill impairment and reduced 2026 guidance, pointing to elevated execution risk and a potential future need for financing if cash burn persists.
Sentiment
weakMarket sentiment is cautious following a negative earnings report and guidance reset, despite some insider buying.
Dominant near-term driver is the Q2 earnings/guidance reset (announced), which drove the most negative coverage, with only modest offsets from insider buying and a Chief Commercial Officer appointment. Media sentiment has deteriorated versus the prior 30–90d window (polarity_score ≈ +0.38 → −0.06); moderate red-flag cap applied due to conflicting actionable signals.
Technical
weakThe stock is in a bearish trend, with price below key moving averages and weak momentum indicators.
Score 2/5: QTRX is attempting to stabilize after a severe earnings-gap breakdown, but the trend stack is still bearish with price below VWAP, EMA9, EMA21, SMA20, SMA50, and SMA200; MACD remains below zero and below signal, while RSI and Williams %R only support a bounce attempt rather than a durable upside reversal.
You’re looking at 2026-08-19 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.